| The international classification of headache disorders, (beta version) Headache Classification Committee of the International Headache Society (IHS) Cephalalgia 33 (9), 629-808, 2013 | 12545 | 2013 |
| Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4) D Bouhassira, N Attal, H Alchaar, F Boureau, B Brochet, J Bruxelle, ... pain 114 (1-2), 29-36, 2005 | 3216 | 2005 |
| Prevalence of chronic pain with neuropathic characteristics in the general population D Bouhassira, M Lantéri-Minet, N Attal, B Laurent, C Touboul Pain 136 (3), 380-387, 2008 | 2200 | 2008 |
| Development and validation of the neuropathic pain symptom inventory D Bouhassira, N Attal, J Fermanian, H Alchaar, M Gautron, E Masquelier, ... Pain 108 (3), 248-257, 2004 | 1500 | 2004 |
| The cost of headache disorders in Europe: the Eurolight project M Linde, A Gustavsson, LJ Stovner, TJ Steiner, J Barré, Z Katsarava, ... European journal of neurology 19 (5), 703-711, 2012 | 859 | 2012 |
| The international classification of headache disorders, (beta version) DA Ettlin Cephalalgia 33 (9), 629-808, 2013 | 656 | 2013 |
| ARISE: a phase 3 randomized trial of erenumab for episodic migraine DW Dodick, M Ashina, JL Brandes, D Kudrow, M Lanteri-Minet, V Osipova, ... Cephalalgia 38 (6), 1026-1037, 2018 | 621 | 2018 |
| The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20 TJ Postma, NK Aaronson, JJ Heimans, MJ Muller, JG Hildebrand, ... European journal of cancer 41 (8), 1135-1139, 2005 | 608 | 2005 |
| The specific disease burden of neuropathic pain: results of a French nationwide survey N Attal, M Lanteri-Minet, B Laurent, J Fermanian, D Bouhassira Pain 152 (12), 2836-2843, 2011 | 515 | 2011 |
| Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind … U Reuter, PJ Goadsby, M Lanteri-Minet, S Wen, P Hours-Zesiger, ... The Lancet 392 (10161), 2280-2287, 2018 | 497 | 2018 |
| The impact of headache in Europe: principal results of the Eurolight project TJ Steiner, LJ Stovner, Z Katsarava, JM Lainez, C Lampl, M Lantéri-Minet, ... The journal of headache and pain 15, 1-11, 2014 | 467 | 2014 |
| Diagnosis and management of migraine in ten steps AK Eigenbrodt, H Ashina, S Khan, HC Diener, DD Mitsikostas, AJ Sinclair, ... Nature Reviews Neurology 17 (8), 501-514, 2021 | 456 | 2021 |
| Anxiety and depression associated with migraine: influence on migraine subjects' disability and quality of life, and acute migraine management M Lantéri-Minet, F Radat, MH Chautard, C Lucas Pain 118 (3), 319-326, 2005 | 433 | 2005 |
| Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study J Schoenen, RH Jensen, M Lanteri-Minet, MJA Láinez, C Gaul, ... Cephalalgia 33 (10), 816-830, 2013 | 421 | 2013 |
| Guidelines for controlled trials of drugs in migraine: A guide for investigators International Headache Society Clinical Trials Subcommittee members:, ... Cephalalgia 32 (1), 6-38, 2012 | 409 | 2012 |
| Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS) LM Bloudek, M Stokes, DC Buse, TK Wilcox, RB Lipton, PJ Goadsby, ... The journal of headache and pain 13, 361-378, 2012 | 391 | 2012 |
| Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? N Attal, C Fermanian, J Fermanian, M Lantéri-Minet, H Alchaar, ... Pain 138 (2), 343-353, 2008 | 383 | 2008 |
| Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations X Moisset, D Bouhassira, JA Couturier, H Alchaar, S Conradi, ... Revue neurologique 176 (5), 325-352, 2020 | 374 | 2020 |
| Prevalence and clinical characteristics of migraine in France P Henry, JP Auray, AF Gaudin, JF Dartigues, G Duru, M Lantéri–Minet, ... Neurology 59 (2), 232-237, 2002 | 353 | 2002 |
| Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic … M Lantéri-Minet, G Duru, M Mudge, S Cottrell Cephalalgia 31 (7), 837-850, 2011 | 341 | 2011 |